NM_014905.5:c.1651-3683T>C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014905.5(GLS):​c.1651-3683T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0866 in 151,546 control chromosomes in the GnomAD database, including 747 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.087 ( 747 hom., cov: 30)

Consequence

GLS
NM_014905.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.148

Publications

5 publications found
Variant links:
Genes affected
GLS (HGNC:4331): (glutaminase) This gene encodes the K-type mitochondrial glutaminase. The encoded protein is an phosphate-activated amidohydrolase that catalyzes the hydrolysis of glutamine to glutamate and ammonia. This protein is primarily expressed in the brain and kidney plays an essential role in generating energy for metabolism, synthesizing the brain neurotransmitter glutamate and maintaining acid-base balance in the kidney. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2012]
STAT1 (HGNC:11362): (signal transducer and activator of transcription 1) The protein encoded by this gene is a member of the STAT protein family. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. The protein encoded by this gene can be activated by various ligands including interferon-alpha, interferon-gamma, EGF, PDGF and IL6. This protein mediates the expression of a variety of genes, which is thought to be important for cell viability in response to different cell stimuli and pathogens. The protein plays an important role in immune responses to viral, fungal and mycobacterial pathogens. Mutations in this gene are associated with Immunodeficiency 31B, 31A, and 31C. [provided by RefSeq, Jun 2020]
STAT1 Gene-Disease associations (from GenCC):
  • autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Illumina, Orphanet
  • immunodeficiency 31B
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
  • Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.125 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GLSNM_014905.5 linkc.1651-3683T>C intron_variant Intron 14 of 17 ENST00000320717.8 NP_055720.3 O94925-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GLSENST00000320717.8 linkc.1651-3683T>C intron_variant Intron 14 of 17 1 NM_014905.5 ENSP00000317379.3 O94925-1

Frequencies

GnomAD3 genomes
AF:
0.0867
AC:
13125
AN:
151452
Hom.:
746
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0240
Gnomad AMI
AF:
0.228
Gnomad AMR
AF:
0.0830
Gnomad ASJ
AF:
0.151
Gnomad EAS
AF:
0.000964
Gnomad SAS
AF:
0.0362
Gnomad FIN
AF:
0.103
Gnomad MID
AF:
0.118
Gnomad NFE
AF:
0.127
Gnomad OTH
AF:
0.101
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0866
AC:
13130
AN:
151546
Hom.:
747
Cov.:
30
AF XY:
0.0850
AC XY:
6294
AN XY:
74042
show subpopulations
African (AFR)
AF:
0.0241
AC:
999
AN:
41372
American (AMR)
AF:
0.0829
AC:
1261
AN:
15216
Ashkenazi Jewish (ASJ)
AF:
0.151
AC:
524
AN:
3470
East Asian (EAS)
AF:
0.000966
AC:
5
AN:
5176
South Asian (SAS)
AF:
0.0358
AC:
172
AN:
4802
European-Finnish (FIN)
AF:
0.103
AC:
1063
AN:
10322
Middle Eastern (MID)
AF:
0.122
AC:
35
AN:
288
European-Non Finnish (NFE)
AF:
0.127
AC:
8655
AN:
67890
Other (OTH)
AF:
0.0994
AC:
209
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
588
1177
1765
2354
2942
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
138
276
414
552
690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.112
Hom.:
219
Bravo
AF:
0.0862
Asia WGS
AF:
0.0230
AC:
81
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
5.4
DANN
Benign
0.74
PhyloP100
0.15
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12185688; hg19: chr2-191814608; API